Suppr超能文献

阿托伐他汀对雄性大鼠骨骼肌的影响及其作用机制的研究。

Investigation of the Effect of Atorvastatin on Skeletal Muscles in Male Rats and the Involved Mechanisms.

机构信息

College of Science, University of Misan, Maysan, Iraq.

出版信息

Arch Razi Inst. 2022 Feb 28;77(1):285-291. doi: 10.22092/ARI.2021.356683.1895. eCollection 2022 Feb.

Abstract

It has been approved that atrovastatin is a preferred treatment for hyperlipidemia. One of the atrovastatin drawbacks would be the detrimental effects on skeletal muscles. Therefore, the current study was designed to evaluate all the skeletal muscles alteration in rats' after administration of atrovastatin and identification the mechanisms involved in these structural alterations in the skeletal muscles. A total of 12 healthy adult male rats () were randomly divided into two groups (n=6). The control group (G1) included rats that received distilled water as the placebo, and the treatment group (G2) included animals that were treated with atorvastatin (80 mg/kg/day) dissolved in distilled water and administrated by a gastric tube for eight weeks. At the end of the experiment, trapezius and vastus medialis muscle tissues were sampled and fixed with 10% formalin for histopathological studies. Atorvastatin administration gave rise to morphological changes in the skeletal muscle fibers and the nerve fibers, including atrophied myofibers, infarction, irregular arrangement of myonuclei, disappearance of nuclei from their normal peripheral position with acute skeletal muscular infarction, and infiltration of accumulated inflammatory cells. Atorvastatin has been revealed to have several adverse effects on the skeletal muscle and the nerve supply. Based on the data in the current study, it is evident that atorvastatin administration for less than two months resulted in some sorts of myotoxic structural changes and apoptosis as evident by deformity and lack of striation degeneration of nuclei, as well as splitting of the muscle fibers in the adult male rats' skeletal muscle.

摘要

阿托伐他汀已被批准为治疗高血脂的首选药物。阿托伐他汀的一个缺点是会对骨骼肌产生不良影响。因此,本研究旨在评估阿托伐他汀给药后大鼠所有骨骼肌的变化,并确定涉及骨骼肌结构变化的机制。

将 12 只健康成年雄性大鼠()随机分为两组(n=6)。对照组(G1)包括接受蒸馏水作为安慰剂的大鼠,治疗组(G2)包括用阿托伐他汀(80mg/kg/天)治疗的动物,该药物溶解在蒸馏水中,并通过胃管给药 8 周。

实验结束时,取样斜方肌和股直肌组织,用 10%福尔马林固定进行组织病理学研究。阿托伐他汀给药导致骨骼肌纤维和神经纤维的形态发生变化,包括萎缩的肌纤维、梗塞、核的不规则排列、核从正常外周位置消失伴急性骨骼肌梗塞,以及累积的炎症细胞浸润。阿托伐他汀已被证明对骨骼肌和神经供应有多种不良影响。

根据本研究的数据,阿托伐他汀给药不到两个月就导致了一些肌毒性结构变化和细胞凋亡,表现为核畸形和条纹缺失、变性,以及成年雄性大鼠骨骼肌的肌纤维分裂。

相似文献

6
Cell death in denervated skeletal muscle is distinct from classical apoptosis.失神经支配骨骼肌中的细胞死亡不同于经典的细胞凋亡。
Anat Rec. 2000 Mar 1;258(3):305-18. doi: 10.1002/(SICI)1097-0185(20000301)258:3<305::AID-AR10>3.0.CO;2-A.
7
PGC-1β modulates statin-associated myotoxicity in mice.PGC-1β 调节小鼠他汀类药物相关的肌肉毒性。
Arch Toxicol. 2019 Feb;93(2):487-504. doi: 10.1007/s00204-018-2369-7. Epub 2018 Dec 3.

本文引用的文献

7
Approach to asymptomatic creatine kinase elevation.无症状性肌酸激酶升高的处理方法。
Cleve Clin J Med. 2016 Jan;83(1):37-42. doi: 10.3949/ccjm.83a.14120.
8
[Statin intolerance and associated muscular dysfunctions].[他汀类药物不耐受及相关肌肉功能障碍]
Med Sci (Paris). 2015 Dec;31(12):1109-14. doi: 10.1051/medsci/20153112014. Epub 2015 Dec 16.
9
Statin-induced myopathies.他汀类药物引起的肌病。
Pharmacol Rep. 2011;63(4):859-66. doi: 10.1016/s1734-1140(11)70601-6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验